The FDA wants companies to develop over-the-counter (OTC) naloxone products to make it easier for people to have access to these important opioid-receptor antagonists.
More than 760,000 people died from a drug overdose since 1999, most after using an opioid.
The agency issued a Federal Register notice that it hopes will facilitate the development and approval of nonprescription naloxone drug products, including by switching some naloxone products from prescription to